Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease
Please discuss with your doctor if you are considering starting any new medication or if you are experiencing side effects or worsening symptoms.
Bleeding-related events as adjacent gynaecological signals Although bleeding is not a vaginal mucosal endpoint, it is clinically adjacent because patients may describe spotting as vaginal bleeding and present alongside discharge/pain
- Katy M
US$ 20.61
US$ 23.63
US$ 25.82
US$ 24.67
US$ 27.13
US$ 26.27
US$ 21.75
US$ 27.12
